|
|
Article: Orthofix Receives FDA Approval for Clinical Investigation of its Cervical-Stim(R).
- Article from:
- PR Newswire
- Article date:
- September 27, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Cervical-Stim to Be Exhibited by Orthofix at the Annual Meeting of the
North American Spine Society on October 21-23 in Chicago -
NEW YORK, Sept. 27 /PRNewswire/ -- Orthofix International N.V. (Nasdaq: OFIX) announced that it received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration for the clinical investigation of the Orthofix Cervical-Stim(R), a non-invasive cervical bone growth stimulator. Based on the same technology as Orthofix's Spinal-Stim(R) product, the Cervical-Stim generates a pulsed, low-energy electromagnetic field (PEMF) to enhance the success rate of cervical fusions among high-risk patients, ...